I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Tyk2 is a tumor suppressor in colorectal cancer:
Stefan Moritsch (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center)
;
Bernadette Mödl (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center)
;
Irene Scharf (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center)
...
hdl:11353/10.1674689. , 2022
Link:
https://doi.org/10.1080/2162402X.2022.2127271
RT Journal T1
Tyk2 is a tumor suppressor in colorectal cancer
UL https://suche.suub.uni-bremen.de/peid=base-ftunivwiendc:oai:phaidra.univie.ac.at:o:1674689&Exemplar=1&LAN=DE A1 Stefan Moritsch (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center) A1 Bernadette Mödl (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center) A1 Irene Scharf (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center) A1 Lukas Janker (Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna) A1 Daniela Zwolanek (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center) A1 Gerald Timelthaler (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center) A1 Emilio Casanova (Department of Pharmacology, Center of Physiology and Pharmacology & Comprehensive Cancer Center, Medical University of Vienna) A1 Maria Sibilia (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center) A1 Thomas Mohr (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center) A1 Lukas Kenner (Institute of Clinical Pathology, Medical University of Vienna) A1 Dietmar Herndler-Brandstetter (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center) A1 Christopher Gerner (Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna) A1 Mathias Müller (Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna) A1 Birgit Strobl (Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna) A1 Robert Eferl (Center for Cancer Research, Medical University of Vienna & Comprehensive Cancer Center) PB Informa UK Limited YR 2022 K1 colitis-associated colorectal cancer K1 azoxymethane AOM K1 dextran sulfate salt DSS K1 indoleamine 2 K1 3-dioxygenase 1 Ido1 K1 interferon gamma JF hdl:11353/10.1674689 LK http://dx.doi.org/https://doi.org/10.1080/2162402X.2022.2127271 DO https://doi.org/10.1080/2162402X.2022.2127271 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)